Phase not reported / not applicableCompletedOBSERVATIONAL
Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism
ClinicalTrials.gov · NCT02728440 · Registry updated: 2016-04-13
- Condition / research focus
- Idiopathic Hypogonadotropic Hypogonadism
- Sponsor
- Gulhane School of Medicine
- Countries with listed sites
- No country reported
- Registry dates and results
- Start: 2010-05. Completion: 2012-12 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- human chorionic gonadotropin, human menopausal gonadotropin (drug) — also listed as: Pregnyl ® Organon hCG 1500 IU, Merional ® ARIS 75 IU
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.